Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications

Abstract The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective glucose metabolism, obesity, cardiovascular disease and an inability to mount an effective immune response to certain pathogenic organisms. Perturbations in key innate immune receptors known as To...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Saket Gupta, Ashwini Maratha, Jakub Siednienko, Anandan Natarajan, Thusitha Gajanayake, Shu Hoashi, Sinéad Miggin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5e5f494fbf684e968ca4a373c602bbd9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5e5f494fbf684e968ca4a373c602bbd9
record_format dspace
spelling oai:doaj.org-article:5e5f494fbf684e968ca4a373c602bbd92021-12-02T16:08:11ZAnalysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications10.1038/s41598-017-07230-82045-2322https://doaj.org/article/5e5f494fbf684e968ca4a373c602bbd92017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07230-8https://doaj.org/toc/2045-2322Abstract The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective glucose metabolism, obesity, cardiovascular disease and an inability to mount an effective immune response to certain pathogenic organisms. Perturbations in key innate immune receptors known as Toll-like receptors (TLRs) and inflammatory mediators such as IL-6, TNFα and IL-1β have been linked with T2DM. Herein, we sought to establish whether patients with T2DM and underlying complications exhibit perturbations in cytokine and TLR expression. Serum cytokine and mRNA levels of cytokines/TLRs in monocytes (M) and neutrophils (N) were measured in a cohort of 112 diabetic patients: good glycaemic control without complications (GC), good glycaemic control with complications (GCC), poor glycaemic control without complications (PC) and poor glycaemic control with complications (PCC) and compared them with 34 non-diabetic volunteers (NGT). Serum cytokine levels were normal in all study participants. In the GC group, cytokine and TLR gene expression were enhanced compared to NGT. In contrast, suppressed cytokine and TLR gene expression were evident in PC, GCC & PCC groups when compared to the GC. In conclusion, whereas serum pro-inflammatory cytokine levels are unaltered in T2DM patients, differences in inflammatory gene profiles exist among the T2DM patient groups.Saket GuptaAshwini MarathaJakub SiednienkoAnandan NatarajanThusitha GajanayakeShu HoashiSinéad MigginNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Saket Gupta
Ashwini Maratha
Jakub Siednienko
Anandan Natarajan
Thusitha Gajanayake
Shu Hoashi
Sinéad Miggin
Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
description Abstract The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective glucose metabolism, obesity, cardiovascular disease and an inability to mount an effective immune response to certain pathogenic organisms. Perturbations in key innate immune receptors known as Toll-like receptors (TLRs) and inflammatory mediators such as IL-6, TNFα and IL-1β have been linked with T2DM. Herein, we sought to establish whether patients with T2DM and underlying complications exhibit perturbations in cytokine and TLR expression. Serum cytokine and mRNA levels of cytokines/TLRs in monocytes (M) and neutrophils (N) were measured in a cohort of 112 diabetic patients: good glycaemic control without complications (GC), good glycaemic control with complications (GCC), poor glycaemic control without complications (PC) and poor glycaemic control with complications (PCC) and compared them with 34 non-diabetic volunteers (NGT). Serum cytokine levels were normal in all study participants. In the GC group, cytokine and TLR gene expression were enhanced compared to NGT. In contrast, suppressed cytokine and TLR gene expression were evident in PC, GCC & PCC groups when compared to the GC. In conclusion, whereas serum pro-inflammatory cytokine levels are unaltered in T2DM patients, differences in inflammatory gene profiles exist among the T2DM patient groups.
format article
author Saket Gupta
Ashwini Maratha
Jakub Siednienko
Anandan Natarajan
Thusitha Gajanayake
Shu Hoashi
Sinéad Miggin
author_facet Saket Gupta
Ashwini Maratha
Jakub Siednienko
Anandan Natarajan
Thusitha Gajanayake
Shu Hoashi
Sinéad Miggin
author_sort Saket Gupta
title Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_short Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_full Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_fullStr Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_full_unstemmed Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
title_sort analysis of inflammatory cytokine and tlr expression levels in type 2 diabetes with complications
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/5e5f494fbf684e968ca4a373c602bbd9
work_keys_str_mv AT saketgupta analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT ashwinimaratha analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT jakubsiednienko analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT anandannatarajan analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT thusithagajanayake analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT shuhoashi analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
AT sineadmiggin analysisofinflammatorycytokineandtlrexpressionlevelsintype2diabeteswithcomplications
_version_ 1718384598461710336